vs
Enact Holdings, Inc.（ACT）与MADRIGAL PHARMACEUTICALS, INC.（MDGL）财务数据对比。点击上方公司名可切换其他公司
MADRIGAL PHARMACEUTICALS, INC.的季度营收约是Enact Holdings, Inc.的1.0倍（$321.1M vs $312.7M），MADRIGAL PHARMACEUTICALS, INC.同比增速更快（210.8% vs 3.6%）
Enact Holdings, Inc.是美国领先的私人抵押贷款保险服务商，为银行、信用社等各类住宅抵押贷款机构提供风险缓释解决方案，帮助首付较低的购房者获得可负担的住房贷款，助力更多美国普通消费者实现安居需求。
本公司是一家美国生物制药企业，成立于2002年，专注于研发新型合成胆汁酸类似物，可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病，以及胆汁酸性腹泻等肠道疾病。
ACT vs MDGL — 直观对比
营收规模更大
MDGL
是对方的1.0倍
$312.7M
营收增速更快
MDGL
高出207.1%
3.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $312.7M | $321.1M |
| 净利润 | — | $-58.6M |
| 毛利率 | — | — |
| 营业利润率 | 71.3% | -18.6% |
| 净利率 | — | -18.2% |
| 营收同比 | 3.6% | 210.8% |
| 净利润同比 | — | 1.4% |
| 每股收益（稀释后） | $1.23 | $-2.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACTMDGL
| Q4 25 | $312.7M | $321.1M | ||
| Q3 25 | $311.5M | $287.3M | ||
| Q2 25 | $304.9M | $212.8M | ||
| Q1 25 | $306.8M | $137.3M | ||
| Q4 24 | $301.8M | $103.3M | ||
| Q3 24 | $309.6M | $62.2M | ||
| Q2 24 | $298.8M | — | ||
| Q1 24 | $291.6M | $0 |
净利润ACTMDGL
| Q4 25 | — | $-58.6M | ||
| Q3 25 | — | $-114.2M | ||
| Q2 25 | — | $-42.3M | ||
| Q1 25 | — | $-73.2M | ||
| Q4 24 | — | $-59.4M | ||
| Q3 24 | — | $-107.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-147.5M |
毛利率ACTMDGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 96.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率ACTMDGL
| Q4 25 | 71.3% | -18.6% | ||
| Q3 25 | 67.4% | -39.7% | ||
| Q2 25 | 70.4% | -22.2% | ||
| Q1 25 | 68.9% | -57.8% | ||
| Q4 24 | 68.9% | -64.8% | ||
| Q3 24 | 74.1% | -187.1% | ||
| Q2 24 | 78.6% | — | ||
| Q1 24 | 70.6% | — |
净利率ACTMDGL
| Q4 25 | — | -18.2% | ||
| Q3 25 | — | -39.8% | ||
| Q2 25 | — | -19.9% | ||
| Q1 25 | — | -53.4% | ||
| Q4 24 | — | -57.5% | ||
| Q3 24 | — | -172.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
每股收益（稀释后）ACTMDGL
| Q4 25 | $1.23 | $-2.55 | ||
| Q3 25 | $1.10 | $-5.08 | ||
| Q2 25 | $1.11 | $-1.90 | ||
| Q1 25 | $1.08 | $-3.32 | ||
| Q4 24 | $1.05 | $-2.50 | ||
| Q3 24 | $1.15 | $-4.92 | ||
| Q2 24 | $1.16 | — | ||
| Q1 24 | $1.01 | $-7.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $582.5M | $198.7M |
| 总债务越低越好 | $744.5M | $339.9M |
| 股东权益账面价值 | $5.4B | $602.7M |
| 总资产 | $6.9B | $1.3B |
| 负债/权益比越低杠杆越低 | 0.14× | 0.56× |
8季度趋势，按日历期对齐
现金及短期投资ACTMDGL
| Q4 25 | $582.5M | $198.7M | ||
| Q3 25 | $545.6M | $295.7M | ||
| Q2 25 | $616.0M | $186.2M | ||
| Q1 25 | $639.0M | $183.6M | ||
| Q4 24 | $602.8M | $100.0M | ||
| Q3 24 | $674.9M | $232.7M | ||
| Q2 24 | $711.3M | — | ||
| Q1 24 | $624.3M | $622.5M |
总债务ACTMDGL
| Q4 25 | $744.5M | $339.9M | ||
| Q3 25 | $744.1M | $339.8M | ||
| Q2 25 | $743.8M | $118.4M | ||
| Q1 25 | $743.4M | $118.0M | ||
| Q4 24 | $743.0M | $117.6M | ||
| Q3 24 | $742.7M | $117.1M | ||
| Q2 24 | $742.4M | — | ||
| Q1 24 | $746.1M | $116.1M |
股东权益ACTMDGL
| Q4 25 | $5.4B | $602.7M | ||
| Q3 25 | $5.3B | $625.7M | ||
| Q2 25 | $5.2B | $696.0M | ||
| Q1 25 | $5.1B | $710.6M | ||
| Q4 24 | $5.0B | $754.4M | ||
| Q3 24 | $5.0B | $777.2M | ||
| Q2 24 | $4.8B | — | ||
| Q1 24 | $4.7B | $850.8M |
总资产ACTMDGL
| Q4 25 | $6.9B | $1.3B | ||
| Q3 25 | $6.9B | $1.4B | ||
| Q2 25 | $6.8B | $1.0B | ||
| Q1 25 | $6.7B | $996.6M | ||
| Q4 24 | $6.5B | $1.0B | ||
| Q3 24 | $6.6B | $1.1B | ||
| Q2 24 | $6.3B | — | ||
| Q1 24 | $6.3B | $1.1B |
负债/权益比ACTMDGL
| Q4 25 | 0.14× | 0.56× | ||
| Q3 25 | 0.14× | 0.54× | ||
| Q2 25 | 0.14× | 0.17× | ||
| Q1 25 | 0.15× | 0.17× | ||
| Q4 24 | 0.15× | 0.16× | ||
| Q3 24 | 0.15× | 0.15× | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 0.16× | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $724.5M | $-133.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-133.8M |
| 自由现金流率自由现金流/营收 | — | -41.7% |
| 资本支出强度资本支出/营收 | — | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ACTMDGL
| Q4 25 | $724.5M | $-133.5M | ||
| Q3 25 | $192.0M | $79.8M | ||
| Q2 25 | $119.5M | $-47.1M | ||
| Q1 25 | $226.7M | $-88.9M | ||
| Q4 24 | $686.3M | $-104.5M | ||
| Q3 24 | $188.1M | $-67.0M | ||
| Q2 24 | $144.7M | — | ||
| Q1 24 | $187.3M | $-149.2M |
自由现金流ACTMDGL
| Q4 25 | — | $-133.8M | ||
| Q3 25 | — | $79.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-104.7M | ||
| Q3 24 | — | $-67.8M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-149.5M |
自由现金流率ACTMDGL
| Q4 25 | — | -41.7% | ||
| Q3 25 | — | 27.5% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -101.3% | ||
| Q3 24 | — | -109.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度ACTMDGL
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 1.3% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACT
暂无分部数据
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |
